COPD
COPD—beyond inhaler therapies with biologics
The emergence of biologic therapies represents one of the most significant advances in COPD management in more than 20 years. Understanding which patients may benefit, how these medicines work, and …
High risk triad: COPD, asthma and heart failure
The coexistence of asthma, COPD and heart failure represents a clinically complex and increasingly prevalent multimorbidity cluster, particularly in ageing populations. By Debbie Rigby, advanced practice pharmacist Learning outcomes After …
Research Roundup
Debbie Rigby rounds up the latest research news Tirzepatide for maintenance of bodyweight reduction in people with obesity (SURMOUNT-MAINTAIN) The SURMOUNT-MAINTAIN trial found that maintaining tirzepatide at the highest tolerated dose helped …
Bisoprolol ‘safe’ in COPD patients: study
RCT results show the cardio-selective beta-blocker is no longer contraindicated in this patient population, says lead Bisoprolol can be safely used in people with chronic obstructive pulmonary disease (COPD), according …
Triple therapy, SABA market growing
What is the cost and utilisation of the inhaler therapies market? Drug utilisation sub-committee investigates the numbers A PBS committee has considered whether reversion to Authority Required (telephone/online) may be …
Concern over rising triple-therapy use
New report shows 130% increase in use of triple therapy for COPD, as well as a 31% drop in spirometry testing rates Patients with COPD who are using triple therapy …
Home medicines reviews and COPD
Home medicines reviews (HMRs) can provide clinically and statistically significant improvements in health-related quality of life, health status, smoking abstinence and adherence to treatment for people living with chronic obstructive …
Credentialed pharmacists could help combat GP time constraints
A study has found pharmacist-led HMRs that targeted treatable traits in COPD patients led to improvements that persisted 12 months later Pharmacist-led medicine reviews should be integrated into clinical practice …
Research roundup
Debbie Rigby rounds up the latest in research news Chronic Obstructive Pulmonary Disease Exacerbations Increase the Risk of Subsequent Cardiovascular Events Results from the COPDGene study show increased risk of …
Research Roundup
Debbie Rigby rounds up the latest in research news Frailty and Exacerbation of Chronic Obstructive Pulmonary Disease Frail patients with COPD have a more unfavourable future risk of acute exacerbations …
Research Roundup
Debbie Rigby takes a look at the latest in research news Management of type 2 diabetes in patients with frailty Newer antihyperglycemic agents such as glucagonlike peptide-1 receptor agonists (GLP1-RAs), …
Research Roundup
Debbie Rigby rounds up the latest in research news Cardiovascular risk assessment in women: which women are suited for menopausal hormone therapy? Individual risk assessment for atherosclerotic cardiovascular disease is …